UTI (likely associated with repeat catheterisation) Urinary storage symptoms (muscular hypertone induced by pain). Of note, according to post-marketing experience, urinary storage symptoms (increased frequency and urgency) have been recorded with very rare frequency. Type of economic evaluation. The economic evaluation will be a cost-effectiveness / cost-utility analysis. Fee for the proposed medical service As a service rendered in an outpatient setting, the type of funding proposed for this service is a fee, payable to the service provider. It is intended that an application seeking the inclusion of iAluRil on the Prostheses List will also be submitted. As with all new MBS Items, the proposed fee for this service will be based on the time taken, the degree of difficulty and the expertise required to perform the service and will be in line with the MBS fee for ‘similar’ services. The proposed service fee will accommodate the following: Professional Time Treating physician or urology nurse: total estimated at 20 minutes (which includes initial patient discussion (5 minutes), preparation of materials (10 minutes), and instillation (5 minutes). Due to the anxiety and pain sometimes associated with these conditions and the area of catheterisation, some patients may also require a pre-instillation admission of a light oral sedative (30 mins prior), adding to the total patient engagement time. Consumables IAluRil (at this point in time) per instillation ranges between $215 - $235 depending upon pharmacy markup. In/out catheter <$10 Latex/rubber gloves <$1 Chlorhexidine solution (prep solution) <$1 Container for residual urine collection <$1 Sterile drapes < $5 Concomittant medications Anaesthetic gel (KY gel or lignocaine syringe) <$2 Light oral sedative <$1 Relevant peri-procedure costs NA. It is anticipated that the MBS scheduled fee will be greater than:
UTI (likely associated with repeat catheterisation) Urinary storage symptoms (muscular hypertone induced by pain). Of note, according to post-marketing experience, urinary storage symptoms (increased frequency and urgency) have been recorded with very rare frequency. Type of economic evaluation. The economic evaluation will be a cost-effectiveness / cost-utility analysis. Fee for the proposed medical service As a service rendered in an outpatient setting, the type of funding proposed for this service is a fee, payable to the service provider. It is intended that an application seeking the inclusion of iAluRil on the Prostheses List will also be submitted. As with all new MBS Items, the proposed fee for this service will be based on the time taken, the degree of difficulty and the expertise required to perform the service and will be in line with the MBS fee for ‘similar’ services. The proposed service fee will accommodate the following: Professional Time Treating physician or urology nurse: total estimated at 20 minutes (which includes initial patient discussion (5 minutes), preparation of materials (10 minutes), and instillation (5 minutes). Due to the anxiety and pain sometimes associated with these conditions and the area of catheterisation, some patients may also require a pre-instillation admission of a light oral sedative (30 mins prior), adding to the total patient engagement time. Consumables IAluRil (at this point in time) per instillation ranges between $215 - $235 depending upon pharmacy markup. In/out catheter <$10 Latex/rubber gloves <$1 Chlorhexidine solution (prep solution) <$1 Container for residual urine collection <$1 Sterile drapes < $5 Concomittant medications Anaesthetic gel (KY gel or lignocaine syringe) <$2 Light oral sedative <$1 Relevant peri-procedure costs NA. It is anticipated that the MBS scheduled fee will be greater than:
1439-FinalProtocol.docx